'The Future Strategies of Cervical Cancer Prevention: What Do We Need to Do Now to Prepare' Forum Facilitates Discussion on the Prevention of Cervical
Cancer in the HPV Vaccine Era
CHICAGO, Sept. 9 /PRNewswire/ -- The Society of Gynecologic Oncologists (SGO) is hosting a Cervical Cancer Prevention Forum on September 12-13, 2008 at the Hotel SAX in Chicago, IL. Approximately 50 key thought leaders will be in attendance to discuss the undefined areas of cervical cancer prevention, identify future research needs and establish follow-up initiatives for the future.
Since the introduction of the prophylactic HPV vaccines, healthcare providers have been faced with a host of questions and challenges concerning the clinical, public health, policy and economic issues regarding the prevention of cervical cancer. SGO, whose vision is "to eradicate gynecologic cancers", felt it was the opportune time to facilitate a larger discussion to answer these mounting questions and provide direction for the future.
"The HPV vaccine is a major technologic advance that has shown considerable promise in preventing the incidence of cervical cancer," states SGO President, Thomas Burke, MD. "As a result, we need to reevaluate the status of cervical cancer by identifying what is needed to more forward to eradicate this women's disease."
SGO invited key representatives from the various populations of clinicians, scientists, physicians and the public policy sector to participate in an informal, interactive discussion moderated by SGO members Levi Downs, MD, Mark Einstein, MD, Thomas Herzog, MD, Warner Huh, MD and Stewart Massad, MD.
"We believe the results of this meeting will have a tremendous impact
on the future of cervical cancer prevention," asserts Dr. Herzog, Chair of
the SGO Education Committee. "The Forum will redefine clinical, public
health, policy and economic issues, as well as create a comprehensive
summary to identify f
|SOURCE Society of Gynecologic Oncologists|
Copyright©2008 PR Newswire.
All rights reserved